Found: 4
Select item for more details and to access through your institution.
Synthesis and pharmacological evaluation of newly detected synthetic cannabinoid receptor agonists AB-4CN-BUTICA, MMB-4CN-BUTINACA, MDMB-4F-BUTICA, MDMB-4F-BUTINACA and their analogs.
- Published in:
- Frontiers in Psychiatry, 2022, v. 13, p. 1, doi. 10.3389/fpsyt.2022.1010501
- By:
- Publication type:
- Article
Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of binding and different CB<sub>1</sub> receptor activation assays: Part I—Synthesis, analytical characterization, and binding affinity for human CB<sub>1</sub> receptors
- Published in:
- Drug Testing & Analysis, 2021, v. 13, n. 7, p. 1383, doi. 10.1002/dta.3037
- By:
- Publication type:
- Article
Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of binding and different CB<sub>1</sub> receptor activation assays—Part II: Structure activity relationship assessment via a β‐arrestin recruitment assay
- Published in:
- Drug Testing & Analysis, 2021, v. 13, n. 7, p. 1402, doi. 10.1002/dta.3035
- By:
- Publication type:
- Article
Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of binding and different CB1 receptor activation assays. Part III: The G protein pathway and critical comparison of different assays
- Published in:
- Drug Testing & Analysis, 2021, v. 13, n. 7, p. 1412, doi. 10.1002/dta.3054
- By:
- Publication type:
- Article